ConMed Corp (CNMD):企業の財務・戦略的SWOT分析

◆英語タイトル:ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14212
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ConMed Corp (CNMD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ConMed Corp (ConMed) is a medical technology company which manufactures and sells surgical devices and instruments for minimally invasive procedures and monitoring. The company’s major products include arthroscopes, reconstructive systems, bronchoscopy devices endoscopic ligator kit, stone removal balloon, trocars, graspers, scissors, suction irrigation devices, thermal tissue fusion system, electrosurgical generators, smoke evacuation pencil, pencil sheath, saws, blades, endomechanical instrumentation, and surgical visualization equipment. ConMed caters its products to orthopedic, general surgery, gynecology, gastroenterology, pulmonology, anesthesiology and sports medicine markets. The company sells its products through direct sales force and medical specialty distributors. It operates in the Americas, Europe, Middle East and Asia-Pacific. ConMed is headquartered in New York, the US.

ConMed Corp Key Recent Developments

Jan 22,2019: CONMED announces fourth quarter and full-year 2018 financial results
Dec 17,2018: Conmed to buy medical products firm Buffalo Filter for $365m
Nov 05,2018: CONMED Corporation to Present at the Jefferies London Healthcare Conference
Nov 01,2018: CONMED announces third quarter 2018 financial results
Aug 01,2018: CONMED announces second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ConMed Corp – Key Facts
ConMed Corp – Key Employees
ConMed Corp – Key Employee Biographies
ConMed Corp – Major Products and Services
ConMed Corp – History
ConMed Corp – Company Statement
ConMed Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ConMed Corp – Business Description
Product Category: General Surgery
Overview
Performance
Product Category: Orthopedic Surgery
Overview
Performance
Geographical Segment: Americas (excluding the US)
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East & Africa
Performance
Geographical Segment: United States
Performance
R&D Overview
ConMed Corp – Corporate Strategy
ConMed Corp – SWOT Analysis
SWOT Analysis – Overview
ConMed Corp – Strengths
ConMed Corp – Weaknesses
ConMed Corp – Opportunities
ConMed Corp – Threats
ConMed Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
ConMed Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 22, 2019: CONMED announces fourth quarter and full-year 2018 financial results
Dec 17, 2018: Conmed to buy medical products firm Buffalo Filter for $365m
Nov 01, 2018: CONMED announces third quarter 2018 financial results
Aug 01, 2018: CONMED announces second quarter 2018 financial results
Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ConMed Corp, Key Facts
ConMed Corp, Key Employees
ConMed Corp, Key Employee Biographies
ConMed Corp, Major Products and Services
ConMed Corp, History
ConMed Corp, Other Locations
ConMed Corp, Subsidiaries
ConMed Corp, Key Competitors
ConMed Corp, Ratios based on current share price
ConMed Corp, Annual Ratios
ConMed Corp, Annual Ratios (Cont...1)
ConMed Corp, Annual Ratios (Cont...2)
ConMed Corp, Interim Ratios
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
ConMed Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ConMed Corp, Performance Chart (2014 - 2018)
ConMed Corp, Ratio Charts
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[ConMed Corp (CNMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Southern Co (SO):電力:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Maquet Holding BV & Co KG:企業の戦略的SWOT分析
    Maquet Holding BV & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Rexel S.A.:企業の戦略・SWOT・財務情報
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrel …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Indivior Plc (INDV):企業の財務・戦略的SWOT分析
    Indivior Plc (INDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ding He Mining Holdings Ltd:企業のM&A・事業提携・投資動向
    Ding He Mining Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ding He Mining Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • ExlService Holdings, Inc.:企業の戦略・SWOT・財務情報
    ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • The Procter & Gamble Co:企業の戦略・SWOT・財務情報
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a drug discovery and development company focusing on transformative cancer drugs. The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and RSV-infection. Medivir also provi …
  • Mirach Energy Ltd (AWO):石油・ガス:M&Aディール及び事業提携情報
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …
  • Hoya Corporation:企業のM&A・事業提携・投資動向
    Hoya Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hoya Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • International Data Group:戦略・SWOT・企業財務分析
    International Data Group - Strategy, SWOT and Corporate Finance Report Summary International Data Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • WPP plc:企業の戦略・SWOT・財務情報
    WPP plc - Strategy, SWOT and Corporate Finance Report Summary WPP plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆